In AD, aberrant activation of cPLA2 has been linked to neuronal dysfunction, synaptic deficits, and blood-brain barrier (BBB) disruption (Stephenson et al., 1996; Kerman et al., 2022; Hegde et al., 2023). The gene discussed is PLA2G4A; the disease is Alzheimer disease.